Cargando…

Effects of Bioreductive Agents, Tirapazamine and Mitomycin C, on Quiescent Cell Populations in Solid Tumors, Evaluated by Micronucleus Assay

Mice bearing transplantable solid tumors received 10 intraperitoneal administrations of 5‐bromo‐2′‐deoxyuridine (BrdU) to label the proliferating (P) tumor cells, and were then irradiated with (60)Cogamma‐rays or injected with cis‐diamminedichloroplatinum (II) (cisplatin). The tumor cells were isola...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masunaga, Shin‐ichiro, Ono, Koji, Hori, Hitoshi, Shibata, Toru, Suzuki, Minoru, Kinashi, Yuko, Takagaki, Masao, Akaboshi, Mitsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1997
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921522/ https://www.ncbi.nlm.nih.gov/pubmed/9369940 http://dx.doi.org/10.1111/j.1349-7006.1997.tb00468.x

Ejemplares similares

Applicability of Combination with Tirapazamine in Boron Neutron Capture Therapy
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

Usefulness of Tirapazamine as a Combined Agent in Chemoradiation and Thermo‐chemoradiation Therapy at Mild Temperatures: Reference to the Effect on Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2000)

Augmentation in Chemosensitivity of Intratumor Quiescent Cells by Combined Treatment with Nicotinamide and Mild Hyperthermia
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1997)

Responses of Total and Quiescent Cell Populations in Solid Tumors to Boron and Gadolinium Neutron Capture Reaction Using Neutrons with Two Different Energy Spectra
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

Changes in the Sensitivity of Intratumor Cells during Fractionated Tirapazamine Administration
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2000)

Effects of Boron Neutron Capture Therapy Using Borocaptate Sodium in Combination with a Tumor‐selective Vasoactive Agent in Mice
por: Ono, Koji, et al.
Publicado: (1998)

Evaluation of the Potential of p‐Boronophenylalaninol as a Boron Carrier in Boron Neutron Capture Therapy, Referring to the Effect on Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2001)

The Combined Effect of Electroporation and Borocaptate in Boron Neutron Capture Therapy for Murine Solid Tumors
por: Ono, Koji, et al.
Publicado: (2000)

Effect of Electroporation on Cell Killing by Boron Neutron Capture Therapy Using Borocaptate Sodium ((10)B‐BSH)
por: Ono, Koji, et al.
Publicado: (1998)

Effect of Tirapazamine, Metformin or Mild Hyperthermia on Recovery From Radiation-Induced Damage in Pimonidazole-Unlabeled Quiescent Tumor Cells
por: Masunaga, Shin-ichiro, et al.
Publicado: (2017)

Relationship between Cell‐killing Efficiency and Number of Platinum Atoms Binding to DNA, RNA, and Protein Molecules in HeLa Cells Treated with cis‐Diamine(glycolato)platinum(II)
por: Akaboshi, Mitsuhiko, et al.
Publicado: (1996)

Cell‐killing Efficiency and Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HeLa Cells Treated with Combinations of trans‐Diammedichloroplatinum(II) and Hyperthermia
por: Akaboshi, Mitsuhiko, et al.
Publicado: (1997)

Impact of the p53 Status of the Tumor Cells on the Effect of Reactor Neutron Beam Irradiation, with Emphasis on the Response of Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2002)

The Effects of Boron Neutron Capture Therapy on Liver Tumors and Normal Hepatocytes in Mice
por: Suzuki, Minoru, et al.
Publicado: (2000)

Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations.
por: Masunaga, S., et al.
Publicado: (1997)

Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine
por: Friery, O P, et al.
Publicado: (2000)

Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).
por: Patterson, A. V., et al.
Publicado: (1995)

Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.
por: Olive, P. L.
Publicado: (1995)

The Effect of p53 Status on Radio-Sensitivity of Quiescent Tumor Cell Population Irradiated With γ-Rays at Various Dose Rates
por: Masunaga, Shin-ichiro, et al.
Publicado: (2018)

Alteration of Radiosensitivity of Quiescent Cell Populations in Solid Tumors Irradiated with X‐Rays Twice at Various Intervals
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1993)

Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population
por: Masunaga, Shin-ichiro, et al.
Publicado: (2013)

DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs?
por: Workman, P., et al.
Publicado: (1989)

Radiosensitivity and Capacity to Recover from Radiation-Induced Damage in Pimonidazole-Unlabeled Intratumor Quiescent Cells Depend on p53 Status
por: Masunaga, Shin-ichiro, et al.
Publicado: (2011)

The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
por: Keohane, A., et al.
Publicado: (1990)

Tirapazamine-cisplatin: the synergy.
por: Gatzemeier, U., et al.
Publicado: (1998)

DNA double-strand break induction in Ku80-deficient CHO cells following Boron Neutron Capture Reaction
por: Kinashi, Yuko, et al.
Publicado: (2011)

An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed (10)B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness
por: Masunaga, Shin-ichiro, et al.
Publicado: (2020)

Electronic structure and reactivity of tirapazamine as a radiosensitizer
por: Romero, José, et al.
Publicado: (2021)

Experimentally determined relative biological effectiveness of cyclotron-based epithermal neutrons designed for clinical BNCT: in vitro study
por: Hu, Naonori, et al.
Publicado: (2023)

Comparison of in vivo Efficacy of Hypoxic Cytotoxin Tirapazamine and Hypoxic Cell Radiosensitizer KU‐2285 in Combination with Single and Fractionated Irradiation
por: Shibata, Toru, et al.
Publicado: (1996)

Development and Validation of a Kilogram-Scale Synthesis of Tirapazamine
por: Lienard, Philippe, et al.
Publicado: (2020)

Toward Hypoxia-Selective DNA-Alkylating Agents Built by Grafting Nitrogen Mustards onto the Bioreductively Activated, Hypoxia-Selective DNA-Oxidizing Agent 3-Amino-1,2,4-benzotriazine 1,4-Dioxide (Tirapazamine)
por: Johnson, Kevin M., et al.
Publicado: (2014)

Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.
por: Brown, J. M.
Publicado: (1998)

Redox Proteomic Profile of Tirapazamine-Resistant Murine Hepatoma Cells
por: Nemeikaitė-Čėnienė, Aušra, et al.
Publicado: (2023)

Bioreductive drugs and the selective induction of tumour hypoxia.
por: Bremner, J. C., et al.
Publicado: (1990)

Bioreduction: the biological activity, characterization, and synthesis of silver
por: KORKMAZ, Nesrin
Publicado: (2020)

Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity
por: Guise, Chris P., et al.
Publicado: (2020)

Kinetics of Flavoenzyme-Catalyzed Reduction of Tirapazamine Derivatives: Implications for Their Prooxidant Cytotoxicity
por: Nemeikaitė-Čėnienė, Aušra, et al.
Publicado: (2019)

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer
por: Suzuki, Minoru, et al.
Publicado: (2014)

Effectiveness of the liver micronucleus assay using juvenile mice
por: NAGASUE, Ritsuko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1tskbf1pal6j18op00crk9jafc